Dr. Reddy's Laboratories
Dr. Reddy's Laboratories accelerates its digital transformation with AVEVA PI System
Dr. Reddy's Laboratories, one of India's largest pharmaceutical manufacturers, operates several certified plants producing medicines, active ingredients, diagnostic kits and biotechnology solutions. The group had to tackle several challenges at once: improve overall equipment effectiveness, strengthen equipment reliability to limit losses from batch failures, and digitize operations that still relied heavily on manual paper printouts. AVEVA PI System was placed at the heart of the digital transformation strategy at its flagship manufacturing site, providing continuous real-time analytics across all processes. The platform monitors production behavior against defined specification limits and supports the group's ambitions for energy consumption, emissions reduction and a paperless goal by 2030. The results are remarkable, with productivity improved by nearly 90%, quality-related costs cut by 40%, and recognition by the World Economic Forum as a global Lighthouse for smart manufacturing.
FAQ
How does AVEVA PI System support smart manufacturing in the pharmaceutical industry?
AVEVA PI System is at the heart of the digital transformation of Dr. Reddy's Laboratories' flagship site, recognized by the World Economic Forum. The platform provides continuous real-time process analysis, monitors production behavior against specification limits and feeds OEE indicators. For a pharmaceutical manufacturer, it is a key tool for combining strict regulatory compliance, productivity and traceability on lines producing medicines, active ingredients and biotechnology solutions.
How can pharmaceutical operations be digitized to go paperless?
AVEVA PI System replaces manual paper outputs with automated collection of contextualized data, accessible in real time. At Dr. Reddy's Laboratories, this digitization supports the ambition of 100% paperless operations by 2030. Electronic traceability facilitates GxP audits, reduces entry errors and frees up operators' time for value-added tasks. It is a pillar of digital transformation in a regulated sector that demands absolute documentary rigor.
What results has Dr. Reddy's Laboratories achieved with AVEVA PI System?
Dr. Reddy's Laboratories achieved a productivity improvement of nearly 90% and a 40% reduction in quality-related costs, while being recognized by the World Economic Forum as a global Lighthouse for smart manufacturing. These results show that AVEVA PI System transforms the industrial performance of a pharmaceutical site by aligning equipment reliability, overall equipment effectiveness (OEE) and quality excellence. It is an exceptional ROI for an investment in real-time data management.
How can OEE be improved and batch-failure losses limited in pharma?
AVEVA PI System continuously monitors the behavior of critical equipment and alerts on drifts before they cause a batch failure. Real-time analysis makes it possible to identify the root causes of unplanned shutdowns, which in pharmaceuticals lead to the destruction of high-value batches. For Dr. Reddy's Laboratories, this improved equipment reliability is a direct lever for improving OEE and reducing the cost of poor quality.
Why is managing Scope 3 emissions strategic for a pharmaceutical company?
Scope 3 emissions cover the upstream and downstream value chain (suppliers, distribution, use) and often exceed direct Scope 1 and 2 emissions. AVEVA PI System provides Dr. Reddy's Laboratories with the reliable data needed to quantify these emissions, engage with suppliers and drive the reduction of landfill waste. It is a prerequisite for credible ESG commitments and for meeting the growing requirements of health authorities and international customers.